The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene - PubMed (original) (raw)
. 2006 Nov;129(Pt 11):3081-90.
doi: 10.1093/brain/awl271.
Affiliations
- PMID: 17071926
- DOI: 10.1093/brain/awl271
The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene
Ian R A Mackenzie et al. Brain. 2006 Nov.
Abstract
The most common pathology in frontotemporal dementia (FTD) is tau-negative, ubiquitin-immunoreactive (ub-ir) neuronal inclusions (FTLD-U). Recently, we identified mutations in the progranulin (PGRN) gene as the cause of autosomal dominant FTLD-U linked to chromosome 17. Here, we describe the neuropathology in 13 patients from 6 different families, each with FTD caused by a different PGRN mutation. The most consistent feature was the presence of ub-ir lentiform neuronal intranuclear inclusions (NII) in the neocortex and striatum. In addition, the neocortex showed moderate-to-severe superficial laminar spongiosis, chronic degenerative changes, ub-ir neurites and well-defined ub-ir neuronal cytoplasmic inclusions (NCI). In the striatum, there were numerous ub-ir neurites. NCI in the hippocampus usually had a granular appearance. In contrast, familial FTLD-U cases without PGRN mutations had no NII, less severe neocortical and striatal pathology and hippocampal NCI that were more often solid. Eight cases in which genetic analysis was not available also had NII and an overall pathology similar to those with proven mutations. None of our cases of FTLD-U without NII showed the same pattern of pathology as those with mutations. These findings suggest that FTD caused by PGRN mutations has a recognizable pathology with the most characteristic feature being ub-ir NII.
Comment in
- Frontotemporal lobar degeneration through loss of progranulin function.
Goedert M, Spillantini MG. Goedert M, et al. Brain. 2006 Nov;129(Pt 11):2808-10. doi: 10.1093/brain/awl291. Brain. 2006. PMID: 17071919 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
- G0400356/MRC_/Medical Research Council/United Kingdom
- P50 AG16574/AG/NIA NIH HHS/United States
- P01 AG017216/AG/NIA NIH HHS/United States
- R01 AG026251/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous